Detalhe da pesquisa
1.
Trends in end-of-life decisions among patients dying in a university hospital oncology ward after implantation of a palliative outpatient clinic.
Acta Oncol
; 61(7): 881-887, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35467470
2.
Electronic patient-reported outcomes and machine learning in predicting immune-related adverse events of immune checkpoint inhibitor therapies.
BMC Med Inform Decis Mak
; 21(1): 205, 2021 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34193140
3.
Incidence of subsequent primary cancers and radiation-induced subsequent primary cancers after low dose-rate brachytherapy monotherapy for prostate cancer in long-term follow-up.
BMC Cancer
; 20(1): 453, 2020 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32434560
4.
Guideline of guidelines: primary monotherapies for localised or locally advanced prostate cancer.
BJU Int
; 122(4): 535-548, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29633514
5.
Improved diagnostics and change of tumour characteristics in breast cancer: a retrospective study over two decades.
Acta Oncol
; 57(10): 1331-1338, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29882462
6.
Cancer costs and outcomes in the Finnish population 2004-2014.
Acta Oncol
; 57(2): 297-303, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28696797
7.
Cancer costs and outcomes for common cancer sites in the Finnish population between 2009-2014.
Acta Oncol
; 57(7): 983-988, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29451406
8.
Hypofractionated stereotactic body radiotherapy for localized prostate cancer - first Nordic clinical experience.
Acta Oncol
; 56(7): 978-983, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28514930
9.
Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium.
Breast Cancer Res
; 18(1): 98, 2016 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27716369
10.
Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers.
Br J Cancer
; 114(3): 298-304, 2016 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26679376
11.
Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors.
PLoS Genet
; 9(3): e1003284, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23544014
12.
Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions.
Genet Epidemiol
; 38(1): 84-93, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24248812
13.
Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis.
BMC Med
; 13: 156, 2015 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26137966
14.
Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival.
BMC Cancer
; 15: 431, 2015 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-26014348
15.
A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients.
BMC Cancer
; 15: 978, 2015 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26674097
16.
Activity and safety of ODM-201 in patients with progressive metastatic castration-resistant prostate cancer (ARADES): an open-label phase 1 dose-escalation and randomised phase 2 dose expansion trial.
Lancet Oncol
; 15(9): 975-85, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24974051
17.
The role of genetic breast cancer susceptibility variants as prognostic factors.
Hum Mol Genet
; 21(17): 3926-39, 2012 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22532573
18.
MnSOD rs4880 and XPD rs13181 polymorphisms predict the survival of breast cancer patients treated with adjuvant tamoxifen.
Acta Oncol
; 53(6): 769-75, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24716840
19.
Outcome of patients with HER2-positive breast cancer treated with or without adjuvant trastuzumab in the Finland Capecitabine Trial (FinXX).
Acta Oncol
; 53(2): 186-94, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23957715
20.
Matriptase-2 gene (TMPRSS6) variants associate with breast cancer survival, and reduced expression is related to triple-negative breast cancer.
Int J Cancer
; 133(10): 2334-40, 2013 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23649491